GT Biopharma Inc (GTBP)
3.75
-0.11
(-2.85%)
USD |
NASDAQ |
May 31, 16:00
3.72
-0.03
(-0.80%)
After-Hours: 20:00
GT Biopharma Enterprise Value: -4.493M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | -4.493M |
| May 30, 2024 | -4.338M |
| May 29, 2024 | -4.805M |
| May 28, 2024 | -4.805M |
| May 24, 2024 | -4.592M |
| May 23, 2024 | -4.281M |
| May 22, 2024 | -2.694M |
| May 21, 2024 | -1.872M |
| May 20, 2024 | 1.244M |
| May 17, 2024 | -5.386M |
| May 16, 2024 | -5.173M |
| May 15, 2024 | -5.485M |
| May 14, 2024 | -5.397M |
| May 13, 2024 | -5.319M |
| May 10, 2024 | -5.216M |
| May 09, 2024 | -5.349M |
| May 08, 2024 | -5.526M |
| May 07, 2024 | -5.347M |
| May 06, 2024 | -5.360M |
| May 03, 2024 | -5.25M |
| May 02, 2024 | -5.395M |
| May 01, 2024 | -5.430M |
| April 30, 2024 | -5.664M |
| April 29, 2024 | -5.516M |
| April 26, 2024 | -5.188M |
| Date | Value |
|---|---|
| April 25, 2024 | -4.626M |
| April 24, 2024 | -4.767M |
| April 23, 2024 | -4.767M |
| April 22, 2024 | -4.587M |
| April 19, 2024 | -4.712M |
| April 18, 2024 | -4.560M |
| April 17, 2024 | -4.325M |
| April 16, 2024 | -4.698M |
| April 15, 2024 | -4.560M |
| April 12, 2024 | -4.422M |
| April 11, 2024 | -4.284M |
| April 10, 2024 | -4.284M |
| April 09, 2024 | -4.076M |
| April 08, 2024 | -4.173M |
| April 05, 2024 | -4.076M |
| April 04, 2024 | -3.783M |
| April 03, 2024 | -3.386M |
| April 02, 2024 | -4.008M |
| April 01, 2024 | -3.856M |
| March 28, 2024 | -7.855M |
| March 27, 2024 | -7.938M |
| March 26, 2024 | -7.896M |
| March 25, 2024 | -7.883M |
| March 22, 2024 | -7.634M |
| March 21, 2024 | -8.711M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-11.47M
Minimum
May 31 2023
510.68M
Maximum
Jun 02 2021
59.90M
Average
27.27M
Median
Sep 27 2022
Enterprise Value Benchmarks
| Cutera Inc | 356.98M |
| Oragenics Inc | 8.699M |
| Outlook Therapeutics Inc | 162.76M |
| 180 Life Sciences Corp | 1.638M |
| Scorpius Holdings Inc | 7.785M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.266M |
| Total Expenses (Quarterly) | 3.091M |
| EPS Diluted (Quarterly) | -1.64 |
| Earnings Yield | -184.6% |